Breaking News on Pharmaceutical Technology

Latest news headlines

Products

Suppliers

LTS teams up with IntelGenx on VersaFilm

26-Jan-2010 - LTS Lohmann Therapie-Systeme (LTS) signs up as manufacturer of drugs that use IntelGenx’s VersaFilm delivery technology.

Patheon to install development capacity at French plant

25-Jan-2010 - Adding development capacity at French solid dose manufacturing plant will provide a “competitive advantage” says CMO Patheon.

Freezer-farm phase of PCT’s cell-therapy plant complete

25-Jan-2010 - Work on “freezer farm” phase of Progenitor Cell Therapy’s (PCTs) new manufacturing facility in Allendale, New Jersey is complete.

Romaco and CRO Ankur complete Siebler StripTab line

25-Jan-2010 - Indian CRO Ankur Drugs and Pharma is a step closer to stating production of Romaco’s Siebler StripTabs now the German firm developed a fully integrated manufacturing line.

SurModics opens 90,000 sq ft site

25-Jan-2010 - SurModics has opened a 90,000 sq ft cGMP manufacturing and development facility in Birmingham, Alabama, US to support its partnerships and shorten time to market.

AMRI plant gains SafeBridge HPAPI certification

21-Jan-2010 - AMRI’s plant in Rensselaer, New York gained SafeBridge potent compound certification this week after an effort that spokesperson Andrea Schulz said istestament to the firm's "willingness to go the extra mile”.

Castle Harlan buys Pretium and Novapak

20-Jan-2010 - Blow-moulded packaging companies Pretium Packaging and Novapak Corporation have been taken over by New-York-based buyout firm Castle Harlan Inc in a deal worth $200m.

Catalent and Compass boost blister capacity

18-Jan-2010 - New Jersey, US-based contractors Catalent Pharma Solutions and Compass Pharma Services expanded their respective blister pack offerings last week, both citing growing drug industry demand.

Lonza to close Riverside API plant

14-Jan-2010 - Lonza will shut down its API plant in Riverside, Pennsylvania, US by the end of the year as part of a plan to cut costs and shift small-molecule production to Asia.

VCI partners for cGMP e-learning

14-Jan-2010 - SyberWorks is collaborating with the Validation and Compliance Institute (VCI) to provide FDA compliance training, including a programme covering cGMP production.

Novavax scales up RSV-F vaccine

13-Jan-2010 - Novavax has completed cGMP scale up of its RSV-F vaccine candidate, with the material being used in preclinical studies, and amended the terms of the H1N1 collaboration with Xcellerex.

News in brief

Gerresheimer opens new insulin pen plant in Brazil

12-Jan-2010 - German healthcare packaging group Gerresheimer says operations at its new Brazilian plant will begin in the near future.

FDA will miss Afrezza deadline; One small delay for MannKind?

11-Jan-2010 - US FDA has missed its review deadline for MannKind’s inhaled insulin candidate Afrezza after failing to complete inspection of third-party contract supplier.

Florida Biologix expands bioreactor and fill capacity

11-Jan-2010 - A recently completed manufacturing and filling capacity expansion will help Florida Biologix meet deadlines and win repeat business according to company director Richard Snyder.

News in brief

API production starts at Evonik's new plant

11-Jan-2010 - Production has begun at the US API plant German chemicals firm Evonik Industries recently bought from drugmaker Eli Lilly.

MPI and Bioject form needle-free pact

06-Jan-2010 - US preclinical CRO MPI Research has formed an alliance with Oregon-based needle-free delivery specialist Bioject Medical Technologies.

Amcor gets US approval for Alcan takeover

05-Jan-2010 - The US Department of Justice (DOJ) has given partial approval for Amcor’s takeover of Alcan after announcing it would now limit its review to Alcan’s Medical Flexible operations.

Rexam to close Nashua plant; appoints new CEO

04-Jan-2010 - Rexam will close its pill and tablet bottle making facility in New Hampshire, US by the end of the year to further align global plastics operations according to new CEO Graham Chipchase

Delays, takeover bids and Puerto Rico hurt 09, but Patheon up about 2010

22-Dec-2009 - Patheon says a slowdown in “outsourcing decision making,” manufacturing problems in Puerto Rico and cost related to JLL’s takeover bid hurt it in fiscal 09.

Merck & Co to buy Avecia Biologics

21-Dec-2009 - US drug major Merck & Co will buy into the UK's contract biologics manufacturing sector with the acquisition of Tees Valley-based Avecia Biologics.

News in brief

Jubilant plans new niacinamide facility

21-Dec-2009 - Jubilant Organosys will build a new niacinamide and 3-Cyanopyridine plant to cater for growing demand in the drug and nutrition industries.

News in brief

India's focus on APIs and generics helped growth in 2009

21-Dec-2009 - The Indian pharmaceutical market was worth $10.8bn (€7.5bn) this year and will more than double in value by 2014 according to a new industry report by Cygnus Business Consulting & Research.

Recipharm moves for Cobra to boost biologics capacity

17-Dec-2009 - Swedish CDMO Recipharm will buy privately-owned group Cobra Biomanufacturing to build its presence in the expanding biologics sector.

News in brief

Lonza wins Femta RA drug manufacturing contract

16-Dec-2009 - Lonza will use its GS (glutamine synthetase) Gene Expression system to produce clinical trial stocks of Femta Pharmaceuticals’ candidate rheumatoid arthritis (RA) treatment, FM101.

Patheon cuts capacity in Puerto Rico after years of difficulties

14-Dec-2009 - Canadian CMO Patheon will consolidate its Puerto Rican activities at its facility in Manati and sell or close its plant in neighbouring Caguas by 2011.

Sign up for your free newsletter